TBX5 and cardiac proliferation
TBX5 和心脏增殖
基本信息
- 批准号:7466052
- 负责人:
- 金额:$ 36.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAddressAdultAntibodiesBinding SitesBiochemical PathwayBiologicalBiological AssayBoxingCardiacCardiac MyocytesCell CycleCell Cycle ProgressionCell Cycle RegulationCell ProliferationCellsCongenital Heart DefectsCyclin D1DevelopmentEmbryoEmbryonic HeartG1 PhaseGene ExpressionGene TargetingGenesGeneticGenetic TranscriptionGoalsGrowth FactorHeartHeart DiseasesHistonesHolt Oram syndromeHumanInterphaseLeadLifeMapsMitogensMolecularMutateMutationPathologyPathway interactionsPhasePhenotypePhylogenetic AnalysisPopulationProteinsPublic HealthPublishingRanaRangeReagentReporterRoleSignal TransductionSpecificityStem cellsTBX5 proteinTechniquesTestingTissuesTransgenesTransgenic OrganismsWestern BlottingXenopusbasechromatin immunoprecipitationcongenital heart disordercyclin E2in vivonovelprogenitorpromoterprotein protein interactionresearch studytranscription factor
项目摘要
DESCRIPTION (provided by applicant): The identification and characterization of the molecular pathways involved in the early steps of cardiac cell proliferation are absolutely critical to understanding the pathologies and treatment of congenital heart disease. However, to date the early molecular pathways that control the progression of the embryonic cardiac cell cycle remain largely unknown. To address these issues, we cloned and characterized the Xenopus T-box gene Tbx5, the gene mutated in the human congenital heart disease Holt Oram syndrome (HOS). We have shown that TBX5 is both necessary and sufficient in vivo for the cardiac G1/S-transition of the cell cycle. From these and other studies, we hypothesize that TBX5 functions to maintain proliferation of cardiac progenitor populations. Xenopus offers an unparalleled opportunity to address this hypothesis due to the access of unlimited embryonic cardiac tissue, the development of cardiac explant assays, the availability EGFP-transgene reporter frogs that mark gene expression domains and mark specific phases of the cell cycle in living cardiac tissues, and our recent description of an extensive panel of antibodies that mark cell cycle components in the developing Xenopus heart. Here we propose to use TBX5 as a starting point to elucidate the molecular networks which control the proliferation of cardiac progenitor cells. This will be accomplished by determining if TBX5 directly regulates cyclin D1 and cyclin E2 in the embryonic heart, characterizing the biological significance of the SIN3B-TBX5 protein-protein interaction in cardiac cell cycle regulation, and through the identification of the endogenous cardiac mitogens which function through TBX5 to regulate the G1 to S transition of the cardiac cell cycle.
PUBLIC HEALTH RELEVANCE The ability to isolate and propagate cell populations that can differentiate into cardiomyocytes in vivo offers the opportunity to treat a wide range of cardiac diseases. This proposal focuses on the characterization of the transcription factor TBX5, the gene mutated in the congenital heart disease Holt Oram syndrome, and its endogenous role in cardiac proliferation. Our immediate goal is to define and characterize the molecular pathways by which TBX5 functions with the overall goal, to use TBX5 as a starting point in an effort to begin to elucidate the pathways and molecular networks which control the survival and proliferation of cardiomyocyte progenitor cells.
描述(由申请人提供):心脏细胞增殖早期步骤中涉及的分子途径的识别和表征对于了解先天性心脏病的病理学和治疗绝对至关重要。然而,迄今为止,控制胚胎心肌细胞周期进展的早期分子途径仍然很大程度上未知。为了解决这些问题,我们克隆并表征了非洲爪蟾 T-box 基因 Tbx5,该基因在人类先天性心脏病 Holt Oram 综合征 (HOS) 中发生突变。我们已经证明,TBX5 在体内对于细胞周期的心脏 G1/S 转变既是必要的也是充分的。根据这些和其他研究,我们假设 TBX5 的功能是维持心脏祖细胞群的增殖。非洲爪蟾为解决这一假说提供了无与伦比的机会,因为可以获取无限的胚胎心脏组织、心脏外植体测定的发展、标记基因表达域和活体心脏组织中细胞周期特定阶段的 EGFP 转基因报告蛙的可用性,以及我们最近描述的一组广泛的抗体,这些抗体标记发育中的非洲爪蟾心脏中的细胞周期成分。在这里,我们建议使用 TBX5 作为起点来阐明控制心脏祖细胞增殖的分子网络。这将通过确定 TBX5 是否直接调节胚胎心脏中的细胞周期蛋白 D1 和细胞周期蛋白 E2、表征 SIN3B-TBX5 蛋白-蛋白相互作用在心脏细胞周期调节中的生物学意义以及通过鉴定通过 TBX5 发挥作用来调节心脏细胞周期的 G1 到 S 转变的内源性心脏有丝分裂原来完成。
公众健康相关性 分离和繁殖可在体内分化为心肌细胞的细胞群的能力为治疗多种心脏病提供了机会。该提案重点关注转录因子 TBX5(先天性心脏病 Holt Oram 综合征中突变的基因)的特征及其在心脏增殖中的内源性作用。我们的近期目标是定义和表征 TBX5 发挥作用的分子途径,总体目标是使用 TBX5 作为起点,努力阐明控制心肌祖细胞存活和增殖的途径和分子网络。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frank Leo Conlon其他文献
Frank Leo Conlon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Frank Leo Conlon', 18)}}的其他基金
Function and regulation of chromatin remodeling complexes in cardiac development and disease
染色质重塑复合物在心脏发育和疾病中的功能和调节
- 批准号:
10540020 - 财政年份:2022
- 资助金额:
$ 36.31万 - 项目类别:
Function and regulation of chromatin remodeling complexes in cardiac development and disease
染色质重塑复合物在心脏发育和疾病中的功能和调节
- 批准号:
10700108 - 财政年份:2022
- 资助金额:
$ 36.31万 - 项目类别:
Function and regulation of chromatin remodeling complexes in cardiac development and disease
染色质重塑复合物在心脏发育和疾病中的功能和调节
- 批准号:
10849290 - 财政年份:2022
- 资助金额:
$ 36.31万 - 项目类别:
Mechanism and Function of Cardiac Transcriptional Repression Networks
心脏转录抑制网络的机制和功能
- 批准号:
10317301 - 财政年份:2021
- 资助金额:
$ 36.31万 - 项目类别:
Mechanism and Function of Cardiac Transcriptional Repression Networks
心脏转录抑制网络的机制和功能
- 批准号:
10688188 - 财政年份:2021
- 资助金额:
$ 36.31万 - 项目类别:
Mechanism and Function of Cardiac Transcriptional Repression Networks
心脏转录抑制网络的机制和功能
- 批准号:
10452617 - 财政年份:2021
- 资助金额:
$ 36.31万 - 项目类别:
Gene Regulatory Networks for Cardiac Morphogenesis
心脏形态发生的基因调控网络
- 批准号:
9332973 - 财政年份:2017
- 资助金额:
$ 36.31万 - 项目类别:
Gene Regulatory Networks for Cardiac Morphogenesis
心脏形态发生的基因调控网络
- 批准号:
9889169 - 财政年份:2017
- 资助金额:
$ 36.31万 - 项目类别:
Cardiac interaction networks as determinants of transcriptional specificity
心脏相互作用网络作为转录特异性的决定因素
- 批准号:
10159116 - 财政年份:2017
- 资助金额:
$ 36.31万 - 项目类别:
Molecular networks of epicardial formation and function
心外膜形成和功能的分子网络
- 批准号:
9384315 - 财政年份:2017
- 资助金额:
$ 36.31万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Research Grant














{{item.name}}会员




